NexImmune, Inc. (NASDAQ:NEXI – Get Free Report)’s share price rose 0.1% on Wednesday . The stock traded as high as $0.10 and last traded at $0.10. Approximately 147 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 17,332 shares. The stock had previously closed at $0.10.
NexImmune Stock Performance
The stock’s fifty day simple moving average is $0.20 and its 200-day simple moving average is $0.49. The stock has a market cap of $139,139.00, a P/E ratio of -0.01 and a beta of 1.91.
About NexImmune
NexImmune, Inc, a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform.
Featured Articles
- Five stocks we like better than NexImmune
- How to Calculate Retirement Income: MarketBeat’s Calculator
- How to Short Sell Stocks Like a Pro: Strategies and Tips
- How to buy stock: A step-by-step guide for beginners
- 3 Steel Stocks Soaring After Tariff Announcements
- What Are Dividends? Buy the Best Dividend Stocks
- Top Analysts’ Picks for 2025: 3 of Morgan Stanley’s Favorites
Receive News & Ratings for NexImmune Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NexImmune and related companies with MarketBeat.com's FREE daily email newsletter.
